The trademark application AMAZE was filed by AstraZeneca UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 7, 2020, and it was registered by office on December 15, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 9 with Computer software, namely, mobile applications for the collection, exchange and analysis of health and medical data to facilitate the co-management of diseases between health care professionals and healthcare recipients.
The mark was filed in class 42 with Software as a service (SAAS) services featuring software for the collection, exchange and analysis of health and medical data to facilitate the co-management of diseases between health care professionals and healthcare recipients.